CIK 0001107421 · Non-accelerated filer<br>Smaller reporting company
Alaunos Therapeutics, Inc.
Sign in to watch- Ticker
- TCRT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841475642
- Phone
- (346) 355-4099
- Business address
- 501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE, FL, 33301
- Former names
- ZIOPHARM ONCOLOGY INC, EASYWEB INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-22 | Postma Robert W Director | Grant or award | +40,000 | 1,241,870 | ||
| 2022-06-22 | Postma Robert W Director | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2022-06-22 | Thistle Mary Director | Grant or award | +40,000 | 45,000 | ||
| 2022-06-22 | Thistle Mary Director | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2022-06-22 | Huang James Director | Grant or award | +80,000 | 188,333 | ||
| 2022-06-22 | Huang James Director | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2022-06-22 | Postma Robert W Director | Grant or award | +40,000 | 1,241,870 | ||
| 2022-06-22 | Postma Robert W Director | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2022-06-22 | Vieser Jaime Director | Grant or award | +40,000 | 745,321 | ||
| 2022-06-22 | Vieser Jaime Director | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2022-06-22 | Bowden Christopher Director | Grant or award | +40,000 | 44,167 | ||
| 2022-06-22 | Bowden Christopher Director | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2022-06-22 | Weis Holger Director | Grant or award | +40,000 | 160,167 | ||
| 2022-06-22 | Weis Holger Director | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2022-03-30 | Boyle Kevin S. Sr. Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +2,000,000 | 2,000,000 | ||
| 2022-03-30 | De Groot Eleanor EVP, Operations | Grant or award · Employee Stock Option (right to buy) | +350,000 | 350,000 | ||
| 2021-12-22 | De Groot Eleanor EVP, Operations | Sale | −20,132 | $1.27 | $26K | 237,106 |
| 2021-12-10 | Lackey Melinda Senior Vice President, Legal | Grant or award · Employee Stock Option (Right to Buy) | +370,000 | 370,000 | ||
| 2021-11-17 | Boyle Kevin S. Sr. Chief Executive Officer | Purchase | +9,116 | $1.40 | $13K | 885,000 |
| 2021-11-16 | Boyle Kevin S. Sr. Chief Executive Officer | Purchase | +884 | $1.40 | $1K | 875,884 |
Page 5 of 16 · 304 trades